Hapten-Modified Polymer Coating for Pharmaceutical Counterfeit Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing counterfeit pharmaceutical products, such as packaging markings and complex tablet shapes, are either easily circumvented or costly and technically complex, making them unsuitable for widespread implementation.
Innovation Solution
A film-forming composition comprising polymers with at least 50% molar content of acrylic acid, methacrylic acid, or itaconic acid monomers, where hapten-type markers are grafted onto the polymer, enabling detection through color reactions with antibody-type reagents on test strips, is used to coat pharmaceutical tablets.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If packaging is marked with bar codes or holograms, then counterfeit detection is improved, but the packaging can be easily opened and refilled with counterfeit tablets
Solution Approach 1:
The patent embeds detectable markers directly within the tablet structure itself (nested inside the product), rather than only on the packaging. This nested approach ensures that even if packaging is compromised, the embedded markers remain intact within the tablet, providing reliable detection capability that cannot be easily removed or replicated by counterfeiters.
Solution Approach 2:
The patent introduces specialized detectable markers as an intermediary element between the tablet and the detection system. These markers (containing magnetic particles, fluorescent compounds, or other detectable substances) serve as a mediator that enables authentication without requiring complex packaging modifications, thus maintaining packaging integrity while enabling reliable detection.
2Measurement precision
If special inks are used for marking solid forms, then counterfeit detection is improved, but expensive specific equipment is required
Solution Approach 1:
The patent incorporates detectable markers directly into the tablet manufacturing process itself, creating a copy of the authentication capability within the product rather than requiring separate marking equipment. This integrates the detection feature into the core product structure, eliminating the need for additional specialized marking equipment.
Solution Approach 2:
The patent changes the physical-chemical parameters of the tablet by incorporating magnetic particles, fluorescent compounds, or other detectable substances during manufacturing. This parameter modification enables detection through simple screening methods (magnetic detection, fluorescence screening) rather than requiring complex specialized equipment.
3Measurement precision
If tablets are produced with complicated geometric shapes, then counterfeit detection is improved, but production cost and technical complexity increase significantly
Solution Approach 1:
The patent extracts the counterfeit detection function from the tablet's geometric shape and places it in the form of incorporated markers. This separation allows tablets to maintain simple, easy-to-manufacture geometries while still providing robust counterfeit detection through the embedded markers, thus reducing production complexity and cost.
Solution Approach 2:
The patent creates a universal authentication solution that can be applied to tablets of any shape or size. The detectable markers serve multiple functions: they enable counterfeit detection, can provide tracking information, and do not interfere with the tablet's therapeutic function. This multi-functional approach eliminates the need for shape modification while maintaining detection capability.
4Measurement precision
If detectable markers are incorporated into tablets, then counterfeit detection is improved, but the markers must not affect tablet effectiveness
Solution Approach 1:
The patent applies the detectable markers locally within specific regions of the tablet or as a thin coating layer, rather than throughout the entire tablet matrix. This localized application ensures that the markers provide sufficient detection signal while minimizing any potential impact on the tablet's therapeutic effectiveness, dissolution profile, or bioavailability.
Solution Approach 2:
The patent uses trace amounts of detectable markers that serve their authentication purpose and then are effectively discarded (excreted) without affecting the tablet's therapeutic function. The markers are present in such small quantities that they do not interfere with the pharmaceutical action, yet provide sufficient signal for counterfeit detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution allows for a simple, effective method to distinguish genuine from counterfeit products, as the markers are detectable in small concentrations without altering the tablet's effectiveness, providing a cost-effective and technically feasible means to combat counterfeiting.
Implementation Method 1
Said markers being detectable by detection 'kits' revealing a color reaction between an antibody-type reagent deposited on a test strip, for example, and said markers
Data Source
Figure 1~2
AI summary
The invention relates to a coating composition (C) including, with regard to 100 wt % thereof: 0.01 to 30 wt % of a polymer (P) including at least 50 mol % of at least one monomer selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid or maleic acid, 15 to 70 wt % of at least one auxiliary coating agent, if required, the remainder being an agent or a mixture of agents selected from at least a plasticizing agent, a coloring agent, a flow-enhancing agent or an inert filler; characterized in that hapten markers are grafted onto a proportion of the weight of said polymer (P) other than zero.